2013
DOI: 10.1016/j.spinee.2013.06.030
|View full text |Cite
|
Sign up to set email alerts
|

An evidence-based clinical guideline for antibiotic prophylaxis in spine surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
94
2
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(104 citation statements)
references
References 24 publications
1
94
2
1
Order By: Relevance
“…We found substantial differences between IWA and non-IWA patients that would suggest differential use, but the patients receiving IWA were surprisingly more likely to have attributes that placed them at lower risk for SSI, such as greater rates of private insurance, lower rates of smoking, and lower rates of prior surgery. This is contrary to the recommendations from the North American Spine Society [19] and may reflect surgeon or site preference, rather than patient risk stratification. These risk factors need to be accounted for when comparing the rates of SSI, and e Based on number of instrumentation levels, decompressive levels and fusion levels.…”
Section: Discussioncontrasting
confidence: 73%
See 1 more Smart Citation
“…We found substantial differences between IWA and non-IWA patients that would suggest differential use, but the patients receiving IWA were surprisingly more likely to have attributes that placed them at lower risk for SSI, such as greater rates of private insurance, lower rates of smoking, and lower rates of prior surgery. This is contrary to the recommendations from the North American Spine Society [19] and may reflect surgeon or site preference, rather than patient risk stratification. These risk factors need to be accounted for when comparing the rates of SSI, and e Based on number of instrumentation levels, decompressive levels and fusion levels.…”
Section: Discussioncontrasting
confidence: 73%
“…Surgical site infection can occur as late as 12 mo or more after skeletal surgery with implants [16][17] and biofilms that form on implants may contribute to SSI in ways that have not been well assessed [18]. Despite these gaps and the uncertain evidence, clinical guidelines from the North American Spine Society include a recommendation to add IWA ''in patients with comorbidities or for those undergoing complicated spine surgery'' [19].…”
mentioning
confidence: 99%
“…34,35 Further, several patient associated risk factors have been identified for SSI including diabetes and obesity. Other risk factors such as smoking are debatable.…”
Section: Discussionmentioning
confidence: 99%
“…Pharmacokinetic studies with intravenous vancomycin have demonstrated difficulties in delivering targeted concentrations even when a continuous intravenous infusion was used after the loading dose (38,46). Increasing the loading dosage of vancomycin runs the risks of adverse events such as hypotension, flushing, rashes, colitis, and Stevens-Johnson Syndrome (45).…”
Section: Parenteral Vancomycin Administrationmentioning
confidence: 99%